K2 Principal Fund, L.P. Pacific Biosciences Of California, Inc. Call Options Transaction History
K2 Principal Fund, L.P.
- $210 Million
- Q3 2024
Call Options
2 transactions
Others Institutions Holding PACB
# of Institutions
254Shares Held
228MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$65.8 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$46.5 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$46.1 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$40 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$34.8 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $443M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...